Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray stock got a boost after the firm said its European invasion plans are to begin in Germany. Other marijuana stocks were mixed Wednesday.

This Marijuana Stock Moves To Begin Its European Invasion In Germany

Tilray, Inc. (NASDAQ: TLRY) said Wednesday it signed an agreement with Pharma GmbH (Cannamedical) through its subsidiary Tilray Portugal Unipessoal Lda.

Tilray Partners With Cannamedical To Export Medical Cannabis To Germany

Is a plunge of 85% or more really in store for one of the biggest Canadian cannabis producers?

This Pot Stock Is Headed for a Massive Meltdown According to 1 Analyst

Aurora Cannabis

Aphria

Canopy Growth

The possibility of pot stocks writing down the value of their goodwill is growing.

Let's Face the Facts: Marijuana Stocks Grossly Overpaid for Their Acquisitions

Given weak earnings results and multiple sell signals, this marijuana stock will likely face continued headwinds.

Tilray Shares Flag Red With Big Trading Activity

Cronos Group

Here's what needs to happen if these marijuana stocks are going to come bouncing back.

Have These Tumbling Cannabis Stocks Hit Bottom Yet?

Is Marijuana Stock Tilray on the Verge of Collapse?

Alliance Data Systems

Applied Materials

Amid broader market gains, these stocks couldn't keep up.

Why Tilray, Alliance Data Systems, and Applied Materials Slumped Today

Once just an icon for pot stock euphoria, TLRY has proven that it can become a relevant player in the global cannabis market. 
The post After Sliding into Mediocrity, Tilray Stock May Be a Buy on This Dip appeared first on InvestorPlace.

After Sliding into Mediocrity, Tilray Stock May Be a Buy on This Dip

This once-vaunted cannabis stock has come nowhere close to meeting investor expectations.

5 Figures That Show Tilray Is a Mess

It’s been a brutal past six months for cannabis investors, with the ETF MANAGERS TR/TIERRA XP LATIN AME (NYSE: MJ) down another 5.9% this week following a big earnings miss from Tilray Inc (NASDAQ: TLRY).

Cannabis Short Sellers Clean Up After Tilray's Earnings Miss

Disappointing Q2 results are causing some investors to bail on the Canadian cannabis producer.

Why Tilray Stock Is Tanking Today

Cannabis company Tilray Inc (NASDAQ: TLRY) reported a 323% year-over-year second-quarter revenue increase Tuesday.

Tilray CEO: Growth Should Continue For 'Quarters And Years'

TLRY stock is trading down after-hours following an earnings miss. But investors should focus on the longer-term strategy, which remains intriguing.

After Earnings, TLRY Stock Remains a Strategy Play

Tilray (TLRY) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

Tilray (TLRY) Catches Eye: Stock Jumps 8.4%

Canadian cannabis company Tilray Inc. TLRY, +8.38% is well-positioned to become a winner in the sector in the long term, Piper Jaffray said Wednesday after the company reported better-than-expected revenue for the second quarter but a widening of losses.

Tilray is well-placed to emerge a winner in the cannabis sector long term, analysts say

Tilray, Inc. (TLRY) CEO Brendan Kennedy on Q2 2019 Results - Earnings Call Transcript

Revenue soared, but there's more to the story with the Canadian cannabis producer's second-quarter update.

3 Things You Need to Know About Tilray's Q2 Results

The Canadian grower and distributor posts a sharp top-line increase thanks to relatively new product categories.

Tilray Q2 Beats on Revenue, Misses on Earnings

Tilray, Inc. (TLRY) delivered earnings and revenue surprises of -39.13% and 14.10%, respectively, for the quarter ended June 2019.

Tilray, Inc. (TLRY) Reports Q2 Loss, Tops Revenue Estimates

The Canadian pot company missed earnings expectations and beat revenue expectations.

Canadian pot company Tilray's stock slips after posting a wider-than-expected loss

Tilray, Inc. (NASDAQ: TLRY) released second-quarter financial results after markets closed Tuesday.

Tilray’s Q2: A Swing and A Miss

Tilray Inc (NASDAQ: TLRY)'s second-quarter revenue rose 371.1% year-over-year to $45.9 million, the Canadian cannabis company said Tuesday.

Tilray Posts Wider-Than-Expected Q2 Loss, Revenue Beat

Cannabis investors will be closely watching TLRY stock after it reports earnings. Here's how to trade Tilray stock from here.

Tilray Stock Is Looking for a Turnaround

MedMen Enterprises Inc.

MedMen stock jumped over the counter on cost-cutting plans. Most Canadian marijuana stocks rose ahead of Tilray earnings due after the close.

News for Tilray Brands Stock (TLRY)